Zobrazeno 1 - 10
of 163
pro vyhledávání: '"Qingfeng Yu"'
Publikováno v:
Frontiers in Nutrition, Vol 11 (2024)
ObjectiveTo investigate an optimal regimen of six drugs, including lactoferrin, probiotics, prebiotics, glutamine, arginine and erythropoietin (EPO), for the prevention of necrotizing enterocolitis (NEC) in preterm infants.MethodsPubMed, Embase, Ovid
Externí odkaz:
https://doaj.org/article/84df9eddf38d4432899702bc20d0cdf0
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 13, p 7468 (2024)
The β3-adrenoceptor agonist mirabegron is available for the treatment of storage symptoms of overactive bladder, including frequency, urgency, and incontinence. The off-target effects of mirabegron include binding to α1-adrenoceptors, which are cen
Externí odkaz:
https://doaj.org/article/0c1ae26c70194cbfbb6eaa9345adfc9d
Autor:
Jie Ma, Mengmeng Zhang, Xiaoyan Liu, Wu Ye, Jili Deng, Feifei Wu, Congli Zhang, Qingfeng Yu, Li Cao, Silin Gan
Publikováno v:
BMJ Open, Vol 14, Iss 1 (2024)
Objectives Multiple myeloma (MM) is a malignant plasma cell disorder. The most widely accepted staging system for MM is the revised International Staging System based on cytogenetic and clinical biomarkers. The circulating clonal plasma cells (CPCs)
Externí odkaz:
https://doaj.org/article/4d36ae80d4154bbdbb448c74bf17934b
Publikováno v:
Shipin Kexue, Vol 44, Iss 6, Pp 57-64 (2023)
The effects of adding different amounts (0.1%–0.5%) of arabic gum (AG) or guar gum (GG), natural polysaccharides with similar molecular mass but different viscosity, on the emulsifying properties of myofibrillar protein (MP) were investigated. The
Externí odkaz:
https://doaj.org/article/b1793037a41f40f787fd287072b13f4e
Publikováno v:
Frontiers in Urology, Vol 3 (2023)
Externí odkaz:
https://doaj.org/article/0ee068923c144aac9efa932d5e6002cb
Autor:
Qingfeng Yu, Chengjie Wu, Yeda Chen, Bingsheng Li, Ruixiao Wang, Ru Huang, Xuechun Li, Di Gu, Xiaolong Wang, Xiaolu Duan, Shujue Li, Yang Liu, Wenqi Wu, Martin Hennenberg, Guohua Zeng
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 7, Pp 1914-1930 (2021)
Overactive bladder (OAB) is the most bothersome symptom in lower urinary tract symptoms (LUTS). Current pharmacologic treatment aims to inhibit detrusor contraction; however, shows unsatisfied efficacy and high discontinuation rate. LIM kinases (LIMK
Externí odkaz:
https://doaj.org/article/45acd86a838d49659c591eec4b20cd77
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Background: The clinical value of the biomarkers of bladder cancer (BC) is limited due to their low sensitivity or specificity. As a biomarker, DLG associated protein 5 (DLGAP5) is a potential cell cycle regulator in cancer cell carcinogenesis. Howev
Externí odkaz:
https://doaj.org/article/2128dd7368a04ee9bcc76012d6d22be8
Autor:
Ziyu Liu, Zhiyuan Guan, Hongyu Lan, Yan Zhao, Zhiming Ye, Daojun Lv, Qingfeng Yu, Ming Wang, Kaoqing Peng, Nanfei Fu, Giorgio Mazzon, Di Gu
Publikováno v:
Frontiers in Surgery, Vol 9 (2022)
BackgroundThe Visual Prostate Symptom Score (VPSS) is used for the assessment of lower urinary tract symptoms (LUTS). It is usually administered by general practitioners (GPs), but in these cases, outcomes do not seem to be reflecting the real condit
Externí odkaz:
https://doaj.org/article/af22c86a9fe44ceda121d5b3d11cfc2c
Publikováno v:
BMC Urology, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Upper urinary tract stones is the most common diseases in urology. Percutaneous nephrolithotomy (PCNL) and ureteroscopic lithotripsy (fURL) are common treatment, but both their efficacy and safety are controversial. Thus we aim to
Externí odkaz:
https://doaj.org/article/1b07aa28b77549d399e1629325985c28
Autor:
Zhaoxing Wu, Haifeng Zhuang, Qingfeng Yu, Xuzhao Zhang, Xudong Jiang, Xiaoya Lu, Ying Xu, Linlin Yang, Bowen Wu, An Ma, Lei Zhang, Xibin Xiao, Yun Liang, Ruilan Gao, Jianping Shen, Rongzhen Xu
Publikováno v:
Translational Oncology, Vol 12, Iss 6, Pp 801-809 (2019)
As a heterogeneous group of clonal disorders, acute myeloid leukemia with internal tandem duplication of fms-like tyrosine kinase 3 (FLT3-ITD) mutation usually shows an inferior prognosis. In the present study, we found that homoharringtonine (HHT),
Externí odkaz:
https://doaj.org/article/50eb55464a5c4aaea816fe50ef184d60